{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T02:37:32Z","timestamp":1790390252369,"version":"4.1.0"},"reference-count":52,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2009,2,17]],"date-time":"2009-02-17T00:00:00Z","timestamp":1234828800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0000381","type":"journal-article","created":{"date-parts":[[2009,2,17]],"date-time":"2009-02-17T18:51:56Z","timestamp":1234896716000},"page":"e381","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":88,"title":["Is Paromomycin an Effective and Safe Treatment against Cutaneous Leishmaniasis? A Meta-Analysis of 14 Randomized Controlled Trials"],"prefix":"10.1371","volume":"3","author":[{"given":"Dae Hyun","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye Jin","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Bleys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza F.","family":"Ghohestani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2009,2,17]]},"reference":[{"key":"ref1","article-title":"Leishmaniasis.","year":"2007"},{"key":"ref2","first-page":"383","article-title":"Cutaneous leishmaniasis in France: towards the end of injectable therapy?","volume":"96","author":"PA Buffet","year":"2003","journal-title":"Bull Soc Pathol Exot"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.actatropica.2004.03.009","article-title":"Comparison of the effectiveness of two topical paromomycin treatments versus meglumine antimoniate for New World cutaneous leishmaniasis.","volume":"91","author":"RX Armijos","year":"2004","journal-title":"Acta Trop"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1590\/S0037-86821996000500007","article-title":"Comparative study between meglumine antimoniato, pentamidine isothianate and aminosidine sulphate, in the treatment cutaneous primary lesions, caused by Leishmania (Viannia) braziliensis (L(V)b).","volume":"29","author":"D Correia","year":"1996","journal-title":"Rev Soc Bras Med Trop"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/0035-9203(94)90237-2","article-title":"Aminosidine (paromomycin) versus sodium stibogluconate for the treatment of American cutaneous leishmaniasis.","volume":"88","author":"NC Hepburn","year":"1994","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1086\/516267","article-title":"Topical paromomycin\/methylbenzethonium chloride plus parenteral meglumine antimonate as treatment for American cutaneous leishmaniasis: controlled study.","volume":"26","author":"J Soto","year":"1998","journal-title":"Clin Infect Dis"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"117","DOI":"10.4269\/ajtmh.1992.47.117","article-title":"Drug resistance in leishmaniasis: its implication in systemic chemotherapy of cutaneous and mucocutaneous disease.","volume":"47","author":"M Grogl","year":"1992","journal-title":"Am J Trop Med Hyg"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.clindermatol.2006.05.008","article-title":"Cutaneous leishmaniasis.","volume":"25","author":"MS Bailey","year":"2007","journal-title":"Clin Dermatol"},{"key":"ref9","first-page":"987","article-title":"Treatment of cutaneous leishmaniasis of acutely necrotizing type (Borovsky disease) with monomycin.","volume":"65","author":"AA Akovbyan","year":"1968","journal-title":"Trop Dis Bull"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1080\/00034983.1968.11686529","article-title":"The effect of antibiotics of the neomycin group on experimental cutaneous leishmaniasis.","volume":"62","author":"RA Neal","year":"1968","journal-title":"Ann Trop Med Parasitol"},{"key":"ref11","first-page":"660","article-title":"An <italic>in vitro<\/italic> model for testing the effect of anti-leishmanial drugs of possible use in topical treatment.","volume":"33","author":"J El-On","year":"1983","journal-title":"Curr Ther Res Clin Exp"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1128\/AAC.26.5.745","article-title":"Development of topical treatment for cutaneous leishmaniasis caused by Leishmania major in experimental animals.","volume":"26","author":"J El-On","year":"1984","journal-title":"Antimicrob Agents Chemother"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/1523-1747.ep12696697","article-title":"Topical treatment of cutaneous leishmaniasis.","volume":"87","author":"J El-On","year":"1986","journal-title":"J Invest Dermatol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/0035-9203(94)90308-5","article-title":"Treatment of \u2018Old World\u2019 cutaneous leishmaniasis with aminosidine ointment: results of an open study in London.","volume":"88","author":"AD Bryceson","year":"1994","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0035-9203(94)90307-7","article-title":"Aminosidine ointments for the treatment of experimental cutaneous leishmaniasis.","volume":"88","author":"RA Neal","year":"1994","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"466","DOI":"10.4269\/ajtmh.2001.65.466","article-title":"Randomized, controlled, double-blind trial of topical treatment of cutaneous leishmaniasis with paromomycin plus methylbenzethonium chloride ointment in Guatemala.","volume":"65","author":"BA Arana","year":"2001","journal-title":"Am J Trop Med Hyg"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1046\/j.1365-2230.2003.01169.x","article-title":"Treatment of cutaneous leishmaniasis with either topical paromomycin or intralesional meglumine antimoniate.","volume":"28","author":"G Faghihi","year":"2003","journal-title":"Clin Exp Dermatol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1111\/j.1365-4632.2004.02597.x","article-title":"Comparing the efficiency of topical paromomycin with intralesional meglumine antimoniate for cutaneous leishmaniasis.","volume":"44","author":"Z Moosavi","year":"2005","journal-title":"Int J Dermatol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11908-005-0021-1","article-title":"Recent developments in leishmaniasis: Epidemiology, diagnosis, and treatment.","volume":"7","author":"J Berman","year":"2005","journal-title":"Curr Infect Dis Rep"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/0035-9203(94)90432-4","article-title":"Hepatotoxicity of sodium stibogluconate therapy for American cutaneous leishmaniasis.","volume":"88","author":"NC Hepburn","year":"1994","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/0035-9203(94)90235-6","article-title":"Limited efficacy of injectable aminosidine as single-agent therapy for Colombian cutaneous leishmaniasis.","volume":"88","author":"J Soto","year":"1994","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref22","first-page":"353","article-title":"Treatment of cutaneous leishmaniasis with aminosidine (paromomycin) ointment: double-blind, randomized trial in the Islamic Republic of Iran.","volume":"81","author":"A Asilian","year":"2003","journal-title":"Bull World Health Organ"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1093\/clinids\/20.1.47","article-title":"Successful treatment of New World cutaneous leishmaniasis with a combination of topical paromomycin\/methylbenzethonium chloride and injectable meglumine antimonate.","volume":"20","author":"J Soto","year":"1995","journal-title":"Clin Infect Dis"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1067\/mjd.2003.218","article-title":"Treatment of cutaneous leishmaniasis by photodynamic therapy.","volume":"48","author":"K Gardlo","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"7798","DOI":"10.1158\/0008-5472.CAN-07-0203","article-title":"Localized hyperthermia combined with intratumoral dendritic cells induces systemic antitumor immunity.","volume":"67","author":"A Mukhopadhaya","year":"2007","journal-title":"Cancer Res"},{"key":"ref26","first-page":"451","article-title":"Intralesional injection of mumps or Candida skin test antigens: a novel immunotherapy for warts.","volume":"137","author":"SM Johnson","year":"2001","journal-title":"Arch Dermatol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1046\/j.1365-4362.1997.00022.x","article-title":"A randomized clinical trial of topical paromomycin versus oral ketoconazole for treating cutaneous leishmaniasis in Turkey.","volume":"36","author":"O Ozgoztasi","year":"1997","journal-title":"Int J Dermatol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/j.1365-2230.2006.02182.x","article-title":"Comparison between the efficacy of photodynamic therapy and topical paromomycin in the treatment of Old World cutaneous leishmaniasis: a placebo-controlled, randomized clinical trial.","volume":"31","author":"A Asilian","year":"2006","journal-title":"Clin Exp Dermatol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1179\/136485905X16372","article-title":"Efficacy of paromomycin ointment in the treatment of cutaneous leishmaniasis: Results of a double-blind, randomized trial in Isfahan, Iran.","volume":"99","author":"F Iraji","year":"2005","journal-title":"Ann Trop Med Parasitol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials.","volume":"7","author":"R DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis.","volume":"21","author":"JP Higgins","year":"2002","journal-title":"Stat Med"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"648","DOI":"10.4269\/ajtmh.1995.53.648","article-title":"A randomized, placebo-controlled trial of a two-week regimen of aminosidine (paromomycin) ointment for treatment of cutaneous leishmaniasis in Iran.","volume":"53","author":"A Asilian","year":"1995","journal-title":"Am J Trop Med Hyg"},{"key":"ref33","first-page":"85","article-title":"Comparison of topical paromomycin sulfate (twice\/day) with intralesional meglumine antimoniate for the treatment of cutaneous leishmaniasis caused by L. major.","volume":"15","author":"B Shazad","year":"2005","journal-title":"Eur J Dermatol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"162","DOI":"10.4269\/ajtmh.1995.53.162","article-title":"A randomized, placebo-controlled trial in Tunisia treating cutaneous leishmaniasis with paromomycin ointment.","volume":"53","author":"AB Salah","year":"1995","journal-title":"Am J Trop Med Hyg"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0035-9203(97)90290-X","article-title":"Non-ulcerative cutaneous leishmaniasis in Honduras fails to respond to topical paromomycin.","volume":"91","author":"FA Neva","year":"1997","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/0035-9203(90)90146-6","article-title":"A double-blind clinical trial of the treatment of cutaneous leishmaniasis with paromomycin ointment.","volume":"84","author":"SH El-Safi","year":"1990","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0190-9622(92)70175-F","article-title":"Topical treatment of Old World cutaneous leishmaniasis caused by Leishmania major: A double-blind control study.","volume":"27","author":"J El-On","year":"1992","journal-title":"J Am Acad Dermatol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.4269\/ajtmh.1986.35.1110","article-title":"Leishmania major: antileishmanial activity of methylbenzethonium chloride.","volume":"35","author":"J El-On","year":"1986","journal-title":"Am J Trop Med Hyg"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/0169-4758(88)90200-1","article-title":"Topical chemotherapy of cutaneous leishmaniasis.","volume":"4","author":"J El-On","year":"1988","journal-title":"Parasitol Today"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.actatropica.2004.10.007","article-title":"Activity of a paromomycin hydrophilic formulation for topical treatment of infections by Leishmania (Leishmania) amazonensis and Leishmania (Viannia) braziliensis.","volume":"93","author":"GS Goncalves","year":"2005","journal-title":"Acta Trop"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"354","DOI":"10.2307\/3285646","article-title":"Successful topical treatment of murine cutaneous leishmaniasis with a combination of paromomycin (Aminosidine) and gentamicin.","volume":"85","author":"M Grogl","year":"1999","journal-title":"J Parasitol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1371\/journal.pntd.0000034","article-title":"Optimization of topical therapy for Leishmania major localized cutaneous leishmaniasis using a reliable C57BL\/6 model.","volume":"1","author":"H Lecoeur","year":"2007","journal-title":"PLoS Negl Trop Dis"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/0035-9203(94)90517-7","article-title":"Topical treatment of American cutaneous leishmaniasis with paramomycin and methylbenzethonium chloride: a clinical study under field conditions in Ecuador.","volume":"88","author":"G Krause","year":"1994","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/jac\/35.5.577","article-title":"The sensitivity of Leishmania species to aminosidine.","volume":"35","author":"RA Neal","year":"1995","journal-title":"J Antimicrob Chemother"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/0190-9622(93)70209-C","article-title":"Topical treatment of New World cutaneous leishmaniasis in Belize: a clinical study.","volume":"29","author":"L Weinrauch","year":"1993","journal-title":"J Am Acad Dermatol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"335.e1","DOI":"10.1016\/j.jaad.2007.01.016","article-title":"Treatment of acute Old World cutaneous leishmaniasis: a systematic review of the randomized controlled trials.","volume":"57","author":"A Khatami","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S1473-3099(07)70209-8","article-title":"Cutaneous leishmaniasis.","volume":"7","author":"R Reithinger","year":"2007","journal-title":"Lancet Infect Dis"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"663","DOI":"10.7326\/0003-4819-134-8-200104170-00012","article-title":"The revised CONSORT statement for reporting randomized trials: explanation and elaboration.","volume":"134","author":"DG Altman","year":"2001","journal-title":"Ann Intern Med"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"657","DOI":"10.7326\/0003-4819-134-8-200104170-00011","article-title":"The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials.","volume":"134","author":"D Moher","year":"2001","journal-title":"Ann Intern Med"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1136\/bmj.323.7304.101","article-title":"Systematic reviews in health care: Investigating and dealing with publication and other biases in meta-analysis.","volume":"323","author":"JA Sterne","year":"2001","journal-title":"BMJ"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1136\/bmj.320.7249.1574","article-title":"Empirical assessment of effect of publication bias on meta-analyses.","volume":"320","author":"AJ Sutton","year":"2000","journal-title":"BMJ"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1517\/13543784.14.11.1337","article-title":"Clinical status of agents being developed for leishmaniasis.","volume":"14","author":"JD Berman","year":"2005","journal-title":"Expert Opin Investig Drugs"}],"container-title":["PLoS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0000381","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T23:03:06Z","timestamp":1558134186000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0000381"}},"subtitle":[],"editor":[{"given":"Simon","family":"Croft","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2009,2,17]]},"references-count":52,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2009,2,17]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0000381","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,2,17]]}}}